Advanced Oncotherapy plc (LON:AVO – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1.77 ($0.02) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares changing hands.
Advanced Oncotherapy Stock Performance
The company has a debt-to-equity ratio of 98.71, a quick ratio of 0.13 and a current ratio of 1.26. The firm has a market cap of £9.49 million, a P/E ratio of -25.00 and a beta of 0.09. The firm’s fifty day moving average price is GBX 1.75 and its 200 day moving average price is GBX 1.77.
Advanced Oncotherapy Company Profile
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
Read More
- Five stocks we like better than Advanced Oncotherapy
- What is the Dow Jones Industrial Average (DJIA)?
- 3 Stocks Leading the U.S. Agriculture Comeback
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- How to Use Put Debit Spreads to Profit From Falling Stocks
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.
